Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

Tadolini, Marina; Codecasa, Luigi Ruffo; García-García, José-María; Blanc, François-Xavier; Borisov, Sergey; Alffenaar, Jan-Willem; Andréjak, Claire; Bachez, Pierre; Bart, Pierre-Alexandre; Belilovski, Evgeny; Cardoso-Landivar, José; Centis, Rosella; D'Ambrosio, Lia; De Souza-Galvão, María-Luiza; Dominguez-Castellano, Angel; Dourmane, Samir; Jachym, Mathilde Fréchet; Froissart, Antoine; Giacomet, Vania; Goletti, Delia; Grard, Soazic; Gualano, Gina; Izadifar, Armine; Le Du, Damien; Royo, Margarita Marín; Mazza-Stalder, Jesica; Motta, Ilaria; Ong, Catherine Wei Min; Palmieri, Fabrizio; Rivière, Frédéric; Rodrigo, Teresa; Rossato Silva, Denise; Sánchez-Montalvá, Adrián; Saporiti, Matteo; Scarpellini, Paolo; Schlemmer, Frédéric; Spanevello, Antonio; Sumarokova, Elena; Tabernero, Eva; Tambyah, Paul Anantharajah; Tiberi, Simon; Torre, Alessandro; Visca, Dina; Murguiondo, Miguel Zabaleta; Sotgiu, Giovanni; Migliori, Giovanni Battista

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate, and capacity to overwhelm healthcare systems [1, 2]. SARS-CoV-2 transmission occurs mainly through droplets, although surface contamination contributes and debate continues on aerosol transmission [3–5].